BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17300766)

  • 1. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
    Stoller DC; Sim-Selley LJ; Smith FL
    Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
    Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
    Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
    Gray RE; Munks MW; Haynes RR; Olsen GD
    Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of antinociceptive efficacy in rat pups infused with morphine from osmotic minipumps.
    Stoller DC; Thornton SR; Smith FL
    Pharmacology; 2002 Sep; 66(1):11-8. PubMed ID: 12169760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
    Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
    Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-induced mu opioid receptor phosphorylation and functional desensitization in rat thalamus.
    Deng HB; Yu Y; Wang H; Guang W; Wang JB
    Brain Res; 2001 Apr; 898(2):204-14. PubMed ID: 11306006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
    Aley KO; Green PG; Levine JD
    J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
    Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
    Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats.
    Schmidt BL; Tambeli CH; Barletta J; Luo L; Green P; Levine JD; Gear RW
    J Neurosci; 2002 Aug; 22(15):6773-80. PubMed ID: 12151557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat.
    Guirimand F; Strimbu-Gozariu M; Willer JC; Le Bars D
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1007-20. PubMed ID: 7912273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice.
    Rady JJ; Fujimoto JM
    J Biomed Sci; 2000; 7(3):258-69. PubMed ID: 10810246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.